메뉴 건너뛰기
International Ophthalmology
Volumn 29, Issue 1, 2009, Pages 33-37
Management of ocular complications of Vogt-Koyanagi-Harada syndrome
Author keywords

Subtenon corticosteroid; Triamcinolone acetonide; Vogt Koyanagi Harada syndrome
Indexed keywords

CYCLOSPORIN; CYCLOSPORIN A; DEFLAZACORT; METHYLPREDNISOLONE; PREDNISOLONE; TRIAMCINOLONE; TRIAMCINOLONE ACETONIDE;
EID: 59149086588     PISSN: 01655701     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10792-007-9159-1     Document Type: Article
Times cited : (15)
References (9)
  • 2
    • 0035025345 scopus 로고    scopus 로고
    • Revised diagnostic criteria for Vpgt-Koyanagi-Harada disease: Report of an international committee on nomenclature
    • Read RW, Holland GN, Rao NA et al (2001) Revised diagnostic criteria for Vpgt-Koyanagi-Harada disease: Report of an international committee on nomenclature. Am J Ophthalmol 131:647-652
    • (2001) Am J Ophthalmol , vol.131 , pp. 647-652
    • Read, R.W.1    Holland, G.N.2    Rao, N.A.3
  • 3
    • 0035021332 scopus 로고    scopus 로고
    • Complications and prognostic factors in Vogt-Koyanagi-Harada disease
    • Read RW, Rechodouni A, Butani N et al (2001) Complications and prognostic factors in Vogt-Koyanagi-Harada disease. Am J Ophthalmol 131:599-606
    • (2001) Am J Ophthalmol , vol.131 , pp. 599-606
    • Read, R.W.1    Rechodouni, A.2    Butani, N.3
  • 4
    • 26844466276 scopus 로고    scopus 로고
    • Vogt-Koyanagi-Harada disease: Clinical outcomes
    • Bykhovskaya I, Thorne JE, Kempen JH et al (2005) Vogt-Koyanagi-Harada disease: Clinical outcomes. Am J Ophthalmol 140:674-678
    • (2005) Am J Ophthalmol , vol.140 , pp. 674-678
    • Bykhovskaya, I.1    Thorne, J.E.2    Kempen, J.H.3
  • 5
    • 33745640944 scopus 로고    scopus 로고
    • Evaluation of the effect on outcomes of the route of administration of corticosteroids in acute Vogt-Koyanagi-Harada disease
    • Read RW, Yu F, Accorinti M et al (2006) Evaluation of the effect on outcomes of the route of administration of corticosteroids in acute Vogt-Koyanagi-Harada disease. Am J Ophthalmol 142:119-124
    • (2006) Am J Ophthalmol , vol.142 , pp. 119-124
    • Read, R.W.1    Yu, F.2    Accorinti, M.3
  • 6
    • 33745876841 scopus 로고    scopus 로고
    • Intravitreal triamcinolone acetonide in Vogt-Koyanagi-Harada syndrome
    • Karacorlu M, Arf Karacorlu S, Ozdemir H (2006) Intravitreal triamcinolone acetonide in Vogt-Koyanagi-Harada syndrome. Eur J Ophthalmol 16:481-483
    • (2006) Eur J Ophthalmol , vol.16 , pp. 481-483
    • Karacorlu, M.1    Arf Karacorlu, S.2    Ozdemir, H.3
  • 7
    • 1542297329 scopus 로고    scopus 로고
    • Intravitreal triamcinolone in the treatment of serous retinal detachment in Vogt-Koyanagi-Harada syndrome
    • Andrade RE, Muccioli C, Farah ME et al (2004) Intravitreal triamcinolone in the treatment of serous retinal detachment in Vogt-Koyanagi-Harada syndrome. Am J Ophthalmol 137:572-574
    • (2004) Am J Ophthalmol , vol.137 , pp. 572-574
    • Andrade, R.E.1    Muccioli, C.2    Farah, M.E.3
  • 8
    • 16344389598 scopus 로고    scopus 로고
    • Complications of intravitreal injection of triamcinolone acetonide
    • Ozkiris A, Erkilic K (2005) Complications of intravitreal injection of triamcinolone acetonide. Can J Ophthalmol 40:63-68
    • (2005) Can J Ophthalmol , vol.40 , pp. 63-68
    • Ozkiris, A.1    Erkilic, K.2
  • 9
    • 33750076677 scopus 로고    scopus 로고
    • Intravitreal triamcinolone acetonide concentration after subtenon injection
    • Thomas ER, Wang J, Ege E et al (2006) Intravitreal triamcinolone acetonide concentration after subtenon injection. Am J Ophthalmol. 142:860-861
    • (2006) Am J Ophthalmol. , vol.142 , pp. 860-861
    • Thomas, E.R.1    Wang, J.2    Ege, E.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.